Surgery Websites
Vascular & Endovascular Surgery »  Meet the Team »  Vascular Surgeons »  Jade S. Hiramoto, M.D.
Jade S. Hiramoto, M.D.

Jade S. Hiramoto, M.D.

  • Professor of Surgery
  • Division of Vascular and Endovascular Surgery

Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
Open Popup

Education

  • 1984-88, North High School, Diploma
  • 1988-92, University of California, Los Angeles, B.Sc. (HON), Molecular, Cellular, and Developmental Biology
  • 1992-96, University of California, San Francisco School of Medicine, M.D.

Residencies

  • 1996-97, University of California, San Francisco, Intern, General Surgery
  • 1997-02, University of California, San Francisco, Resident, General Surgery
  • 2002-03, University of California, San Francisco, Chief Resident, General Surgery

Fellowships

  • 2003-04, University of California, San Francisco, Fellow, Interventional Radiology
  • 2004-05, University of California, San Francisco, Fellow, Vascular Surgery

Postdoctoral Training

  • 2005-06, University of California, San Francisco Dept. of Epidemiology and Biostatistics, Postdoctoral Fellow, Clinical Research

Board Certifications

  • American Board of Surgery
  • American Board of Surgery, Vascular Surgery

Clinical Expertise

  • Carotid artery disease
  • Lower extremity arterial and venous disorders
  • Renovascular disease
  • Thoracic and abdominal aortic aneurysms and dissections
  • Varicose veins
  • Venous insufficiency

Research Interests

  • Gender differences in vascular surgical outcomes
  • Hemodynamic changes after aortic stent-graft placement
  • Inflammatory response and kidney injury after complex endovascular procedures
  • Spinal perfusion after endovascular thoracoabdominal aortic aneurysm repair

Biography

Dr. Jade Hiramoto is a vascular surgeon with expertise in both minimally invasive endovascular techniques as well as open surgical interventions. Her clinical areas of expertise include open and endovascular repair of thoracic and abdominal aortic aneurysms and dissections, carotid artery disease, renovascular disease, and lower extremity arterial and venous disorders.

 

Dr. Hiramoto earned her medical degree from the University of California, San Francisco School of Medicine. She completed her residency in general surgery, as well as fellowships in both interventional radiology and vascular surgery at the University of California San Francisco. She is currently a Professor of Surgery with the UCSF Division of Vascular and Endovascular Surgery.

Research Overview

Dr. Hiramoto's research involves both clinical and translational research, with a special interest in the abnormal inflammatory response and kidney injury after complex endovascular aortic procedures. She is also interested in gender-based differences in the treatment and outcomes of vascular disease. Dr. Hiramoto is an investigator on several clinical trials, including the use of endovascular stent-grafts for treatment of abdominal and thoracic aortic aneurysms, the use of carotid stents for prevention of stroke, and the measurement of pressure changes in the aorta after placement of stent-grafts to treat aneurysms.

Clinical Trials

Data provided by UCSF Profiles, powered by CTSI

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 93
Data provided by UCSF Profiles, powered by CTSI
  1. Huynh C, Liu I, El Khoury R, Zhou B, Braun H, Conte MS, Hiramoto J. Iliac artery calcification score stratifies mortality risk estimation in patients with chronic limb-threatening ischemia undergoing revascularization. J Vasc Surg. 2023 07; 78(1):184-192. View in PubMed
  2. Sanders KM, Nacario JH, Smith EJT, Jaramillo EA, Lancaster EM, Hiramoto JS, Conte MS, Iannuzzi JC. Structured discharge documentation reduces sex-based disparities in statin prescription in vascular surgery patients. J Vasc Surg. 2023 05; 77(5):1504-1511. View in PubMed
  3. Liu IH, El Khoury R, Wu B, Gasper WJ, Schneider PA, Hiramoto JS, Vartanian SM, Conte MS. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia. J Vasc Surg. 2023 04; 77(4):1137-1146.e3. View in PubMed
  4. Jaramillo EA, Smith EJT, Matthay ZA, Sanders KM, Hiramoto JS, Gasper WJ, Conte MS, Iannuzzi JC. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention. J Vasc Surg. 2023 03; 77(3):848-857.e2. View in PubMed
  5. O'Banion LA, Qumsiyeh Y, Matheny H, Siada SS, Yan Y, Hiramoto JS, Rome C, Dirks RC, Prentice A. Lower extremity amputation protocol: a pilot enhanced recovery pathway for vascular amputees. J Vasc Surg Cases Innov Tech. 2022 Dec; 8(4):740-747. View in PubMed
  6. View All Publications

Videos

Data provided by UCSF Profiles, powered by CTSI
  1. UCSF Vascular Care Symposium - Gender Differences in PAD: Implications for Treatment

In the News

  • Jade Hiramoto, MD Named President-Elect of UCSF Medical Staff

    UCSF Vascular Surgery - Lauren Washburn - July 16, 2020
    Jade Hiramoto, MD, Professor of Surgery in the UCSF Division of Vascular & Endovascular Surgery, has been named President-Elect of the UCSF Medical Staff. The appointment began on July 1, 2020 and will continue for the next two years. In this role, Dr. Hiramoto will serve as Chair of the Credentials Committee, as well as member of the Executive Medical Board (EMB) and Governance Advisory Council (GAC). Beginning in July 2022, Dr. Hiramoto will become President of the Medical Staff where [...]

 

 
Site Directory
    X